These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26628614)

  • 1. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport.
    George RT; Abuhatzira L; Stoughton SM; Karathanasis SK; She D; Jin C; Buss NAPS; Bakker-Arkema R; Ongstad EL; Koren M; Hirshberg B
    J Am Heart Assoc; 2021 Jul; 10(13):e014572. PubMed ID: 34121413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.
    Rousset X; Vaisman B; Auerbach B; Krause BR; Homan R; Stonik J; Csako G; Shamburek R; Remaley AT
    J Pharmacol Exp Ther; 2010 Oct; 335(1):140-8. PubMed ID: 20605907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans.
    Reyes-Soffer G; Matveyenko A; Lignos J; Matienzo N; Santos Baez LS; Hernandez-Ono A; Yung L; Nandakumar R; Singh SA; Aikawa M; George R; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1407-1418. PubMed ID: 38695168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
    Ossoli A; Simonelli S; Varrenti M; Morici N; Oliva F; Stucchi M; Gomaraschi M; Strazzella A; Arnaboldi L; Thomas MJ; Sorci-Thomas MG; Corsini A; Veglia F; Franceschini G; Karathanasis SK; Calabresi L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):915-924. PubMed ID: 30894011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design.
    Bonaca MP; George RT; Morrow DA; Bergmark BA; Park JG; Abuhatzira L; Vavere AL; Karathanasis SK; Jin C; She D; Hirshberg B; Hsia J; Sabatine MS
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):243-252. PubMed ID: 33493256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects.
    Carlson LA; Holmquist L
    Acta Med Scand; 1985; 218(2):197-205. PubMed ID: 4061123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
    J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
    Dullaart RP; Gansevoort RT; Dikkeschei BD; de Zeeuw D; de Jong PE; Van Tol A
    Kidney Int; 1993 Jul; 44(1):91-7. PubMed ID: 8355471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
    Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
    Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of pregnenolone- and dehydroepiandrosterone-fatty acid esters by lecithin-cholesterol acyltransferase in human plasma high density lipoproteins.
    Lavallée B; Provost PR; Belanger A
    Biochim Biophys Acta; 1996 Feb; 1299(3):306-12. PubMed ID: 8597585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
    Norum KR; Glomset JA; Nichols AV; Forte T; Albers JJ; King WC; Mitchell CD; Applegate KR; Gong EL; Cabana V
    Scand J Clin Lab Invest Suppl; 1975; 142():31-55. PubMed ID: 169567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness.
    Dullaart RP; Perton F; Sluiter WJ; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4860-6. PubMed ID: 18782872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.